載入...
Next generation therapeutics for inflammatory bowel disease
Tumor necrosis factor (TNF)-antagonists are the cornerstone of therapy for moderately-severely active inflammatory bowel disease (IBD). Although our understanding of pharmacokinetics, pharmacodynamics, and treatment optimization for these agents has evolved considerably over the past decade, a subst...
Na minha lista:
| 發表在: | Curr Gastroenterol Rep |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5901649/ https://ncbi.nlm.nih.gov/pubmed/27461274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11894-016-0522-0 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|